Early Prediction of Response to Chemoradiotherapy for Head and Neck Cancer Reliability of Restaging With Combined Positron Emission Tomography and Computed Tomography

被引:33
作者
Malone, James P. [1 ]
Gerberi, Michael A. T. [1 ]
Vasireddy, Syam [2 ,4 ]
Hughes, Larry F. [1 ]
Rao, Krishna [3 ]
Shevlin, Bruce [5 ]
Kuhn, Matthew [2 ,4 ]
Collette, Dean [2 ,4 ]
Tennenhouse, Joel [2 ,4 ]
Robbins, K. Thomas [1 ]
机构
[1] So Illinois Univ, Sch Med, Dept Surg, Springfield, IL 62794 USA
[2] So Illinois Univ, Sch Med, Dept Radiol, Springfield, IL 62794 USA
[3] So Illinois Univ, Sch Med, Dept Internal Med, Springfield, IL 62794 USA
[4] St Johns Hosp, Dept Radiol, Springfield, IL USA
[5] St Johns Hosp, Dept Radiat Oncol, Springfield, IL USA
关键词
SQUAMOUS-CELL CARCINOMA; STAGE-IV HEAD; RADIATION-THERAPY; FOLLOW-UP; FDG PET; DISSECTION; CHEMORADIATION; RADIOTHERAPY; UTILITY; CT;
D O I
10.1001/archoto.2009.152
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Objective: To assess the role of combined positron emission tomography and computed tomography (PET-CT) in predicting early treatment response at the primary site and in the neck after chemoradiotherapy (CRT) for advanced squamous cell carcinoma of the head and neck (SCCHN). Design: Retrospective analysis with a median follow-up of 24 months. Setting: Academic, tertiary referral center. Patients and Interventions: Thirty-one patients who were treated with concomitant intra-arterial CRT underwent PET-CT 6 to 8 weeks after the completion of treatment. Patients with findings on the physical examination, CT, or PET-CT indicative of persistent disease underwent appropriate surgical intervention for pathological assessment. Patients with a complete clinical response were observed with routine follow-up physical examination for disease recurrence. No evidence of disease at least 6 months after the completion of PET-CT was considered confirmation of complete clinical response. Main Outcome Measures: Presence or absence of residual or recurrent disease during the follow-up period was used to calculate the sensitivity, specificity, and positive and negative predictive values of PET-CT for the primary site and the neck. Results: Assessment of tumor response at the primary site with PET-CT had a sensitivity, specificity, and positive and negative predictive values of 83%, 54%, 31%, and 92%, respectively. In patients with pretreatment N1 to N3 disease, the sensitivity, specificity, and positive and negative predictive values of posttreatment PET-CT were 75%, more than 94%, more than 75%, and 94%, respectively, and the specificity and negative predictive value for patients with pretreatment N0 disease in the neck were 92% and more than 92%, respectively. Conclusions: Negative PET-CT findings accurately determine early disease response at the primary site and in the neck. False-positive findings are common at the primary site. Patients with a negative PET-CT finding after the completion of intra-arterial CRT do not require surgical intervention.
引用
收藏
页码:1119 / 1125
页数:7
相关论文
共 25 条
[1]   Posttreatment assessment of response using FDG-PET/CT for patients treated with definitive radiation therapy for head and neck cancers [J].
Andrade, Regiane S. ;
Heron, Dwight E. ;
Degirmenci, Berna ;
Filho, Pedro A. A. ;
Branstetter, Barton F. ;
Seethala, Raja R. ;
Ferris, Robert L. ;
Avril, Norbert .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 65 (05) :1315-1322
[2]   Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer [J].
Argiris, A ;
Stenson, KM ;
Brockstein, BE ;
Mittal, BB ;
Pelzer, H ;
Kies, MS ;
Jayaram, P ;
Portugal, L ;
Wenig, BL ;
Rosen, FR ;
Haraf, DJ ;
Vokes, EE .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2004, 26 (05) :447-455
[3]   Update on chemoradiotherapy for head and neck cancer [J].
Argiris, A .
CURRENT OPINION IN ONCOLOGY, 2002, 14 (03) :323-329
[4]   Head and neck malignancy: Is PET/CT more accurate than PET or CT alone? [J].
Branstetter, BF ;
Blodgett, TM ;
Zimmer, LA ;
Snyderman, CH ;
Johnson, JT ;
Raman, S ;
Meltzer, CC .
RADIOLOGY, 2005, 235 (02) :580-586
[5]   Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer [J].
Brizel, DM ;
Prosnitz, RG ;
Hunter, S ;
Fisher, SR ;
Clough, RL ;
Downey, MA ;
Scher, RL .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 58 (05) :1418-1423
[6]   PET-CT vs contrast-enhanced CT: What is the role for each after chemoradiation for advanced oropharyngeal cancer? [J].
Chen, AY ;
Vilaseca, I ;
Hudgins, PA ;
Schuster, D ;
Halkar, R .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2006, 28 (06) :487-495
[7]   Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer [J].
Forastiere, AA ;
Goepfert, H ;
Maor, M ;
Pajak, TF ;
Weber, R ;
Morrison, W ;
Glisson, B ;
Trotti, A ;
Ridge, JA ;
Chao, C ;
Peters, G ;
Lee, DJ ;
Leaf, A ;
Ensley, J ;
Cooper, J .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (22) :2091-2098
[8]   Planned neck dissection after concomitant radiochemotherapy for advanced head and neck cancer [J].
Frank, DK ;
Hu, KS ;
Culliney, BE ;
Persky, MS ;
Nussbaum, M ;
Schantz, SP ;
Malamud, SC ;
Holliday, RA ;
Khorsandi, AS ;
Sessions, RB ;
Harrison, LB .
LARYNGOSCOPE, 2005, 115 (06) :1015-1020
[9]   Imaging literature and terminology: When is it residual cancer and when recurrence? [J].
Goerres, GW ;
Stoeckli, SJ .
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2004, 130 (01) :120-121
[10]   Positron emission tomography in the early follow-up of advanced head and neck cancer [J].
Goerres, GW ;
Schmid, DT ;
Bandhauer, F ;
Huguenin, PU ;
von Schulthess, GK ;
Schmid, S ;
Stoeckli, SJ .
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2004, 130 (01) :105-109